GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (OTCPK:ORINY) » Definitions » Price-to-Funds-From-Operations

Orion Oyj (Orion Oyj) Price-to-Funds-From-Operations : (As of May. 17, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Orion Oyj Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Orion Oyj (Orion Oyj) Business Description

Industry
Address
Orionintie 1, P.O. Box 65, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company primarily focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries and North America.